CARLISLE COMPANIES Reports Q2 FY2023 Earnings Results on July 26, 2023

July 29, 2023

🌥️Earnings Overview

On July 26, 2023, CARLISLE COMPANIES ($NYSE:CSL) reported their earnings results for the second quarter of Fiscal Year 2023, ending June 30, 2023. Total revenue for the quarter amounted to USD 1525.9 million, a year-on-year decrease of 17.4%. Net income for the period decreased by 35.5% compared to the same time last year, amounting to USD 194.6 million.

Price History

On Wednesday, the stock opened at $267.8 and closed at $273.4, representing an increase of 1.7% from the previous closing price of $268.8. This marked a significant jump in stock value for CARLISLE COMPANIES, and investors reacted positively to the news. While the company is still facing some challenges due to the pandemic, this positive report indicates that it is still on track for long-term success. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Carlisle Companies. More…

    Total Revenues Net Income Net Margin
    6.02k 774.4 12.9%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Carlisle Companies. More…

    Operations Investing Financing
    1.15k -153.9 -959.2
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Carlisle Companies. More…

    Total Assets Total Liabilities Book Value Per Share
    7.18k 4.14k 59.49
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Carlisle Companies are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    10.4% 24.5% 17.9%
    FCF Margin ROE ROA
    16.2% 22.1% 9.4%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    At GoodWhale, we’ve been analyzing CARLISLE COMPANIES and their financials. Our Risk Rating shows that CARLISLE COMPANIES is a medium risk investment in terms of financial and business aspects. We’ve also detected two risk warnings in the income sheet, which are non-financial in nature. If you’re interested in learning more, you can register with us to view the details and get the full picture. We believe it’s important to be well-informed when making financial decisions, which is why we provide accurate and up-to-date information about companies like CARLISLE COMPANIES. With GoodWhale, you can trust that you’re getting the best advice and data. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    The company operates in three segments: Carlisle Construction Materials, Carlisle Interconnect Technologies, and Carlisle Brake & Friction. Schweiter Technologies AG, Forbo Holding AG, and Sankyo Tateyama Inc. are all competitors of Carlisle Companies Inc.

    – Schweiter Technologies AG ($OTCPK:SCWTF)

    Schweiter Technologies AG is a publicly traded company with a market capitalization of 1.03 billion as of 2022. The company has a return on equity of 7.24%. Schweiter Technologies AG is engaged in the development, manufacture and marketing of textile machines, precision tools and related services. The company’s products are used in the textile, automotive, aerospace and other industries.

    – Forbo Holding AG ($LTS:0QKD)

    Forbo Holding AG is a Swiss manufacturer of floor coverings, adhesives and other specialty products. The company has a market capitalization of 1.77 billion as of 2022 and a return on equity of 21.17%. Forbo produces a wide range of products for both commercial and residential applications, including vinyl and linoleum flooring, carpet tiles, adhesives, sealants and coatings. The company has a strong presence in Europe and Asia, and is expanding its operations in North America and South America.

    – Sankyo Tateyama Inc ($TSE:5932)

    Sankyo Tateyama Inc is a Japanese company that manufactures and sells pharmaceuticals and medical devices. The company has a market cap of 17.4 billion as of 2022 and a return on equity of 0.94%. The company’s products include drugs for the treatment of hypertension, diabetes, and dyslipidemia, as well as medical devices such as blood pressure monitors and glucose meters.

    Summary

    Carlisle Companies has reported their financial results for the second quarter of FY2023. Net income was $194.6 million, a decrease of 35.5%. This is an indication that the company is not performing as well as it did in the same period of the previous year.

    Investors should thoroughly research the company’s fundamentals, financials, and management team to determine whether the stock is worth investing in. Furthermore, it’s important to consider the competitive landscape and macroeconomic conditions in order to understand the company’s relative performance.

    Recent Posts

    Leave a Comment